(Q48039333)

7 February 2018

title

Health-related quality of life in patients with alpha-1 antitrypsin deficiency: the French experience. (English)

1 reference

7 February 2018

alpha-1-antitrypsin deficiency

1 reference

1 reference

Antoine Cuvelier

4

0 references

author name string

Clément Gauvain

1

1 reference

7 February 2018

Jean-François Mornex

2

1 reference

7 February 2018

Christophe Pison

3

1 reference

7 February 2018

Malika Balduyck

5

1 reference

7 February 2018

Marie-Christine Pujazon

6

1 reference

7 February 2018

Michel Fournier

7

1 reference

7 February 2018

Brahim AitIlalne

8

1 reference

7 February 2018

Gabriel Thabut

9

1 reference

7 February 2018

language of work or name

English

0 references

publication date

1 May 2015

1 reference

7 February 2018

COPD: Journal of Chronic Obstructive Pulmonary Disease

published in

1 reference

7 February 2018

volume

12 Suppl 1

1 reference

7 February 2018

page(s)

46-51

1 reference

7 February 2018

A review of α1-antitrypsin deficiency

cites work

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2015.1022645

The selective advantage of alpha1-antitrypsin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2015.1022645

Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2015.1022645

Genetic epidemiology of alpha‐1 antitrypsin deficiency in North America and Australia/New Zealand: Australia, Canada, New Zealand and the United States of America

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2015.1022645

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2015.1022645

Changes in forced expiratory volume in 1 second over time in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2015.1022645

Usefulness of the CAT, LCOPD, EQ-5D and COPDSS scales in understanding the impact of lung disease in patients with alpha-1 antitrypsin deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2015.1022645

Global Initiative for Chronic Obstructive Lung Disease 2011 symptom/risk assessment in α1-antitrypsin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2015.1022645

Performance of the BODE index in patients with 1-antitrypsin deficiency-related COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2015.1022645

10.3109/15412555.2015.1022645

21 January 2018

Identifiers

DOI

1 reference

7 February 2018

release_4dpj5cryy5dpjapyqmt3fk4ubi

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4dpj5cryy5dpjapyqmt3fk4ubi

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

25938292

1 reference

7 February 2018